| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2012-09-06 15:16:50 UTC |
|---|
| Update Date | 2022-03-07 02:51:46 UTC |
|---|
| HMDB ID | HMDB0014856 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Adefovir Dipivoxil |
|---|
| Description | Adefovir Dipivoxil is only found in individuals that have used or taken this drug.Adefovir dipivoxil, previously called bis-POM PMEA, with trade names Preveon and Hepsera, is an orally-administered nucleotide analog reverse transcriptase inhibitor (ntRTI) used for treatment of hepatitis B. It is a failed treatment for HIV. [Wikipedia ]Adefovir dipivoxil is a prodrug of adefovir. Adefovir is an acyclic nucleotide analog of adenosine monophosphate which is phosphorylated to the active metabolite adefovir diphosphate by cellular kinases. Adefovir diphosphate inhibits HBV DNA polymerase (reverse transcriptase) by competing with the natural substrate deoxyadenosine triphosphate and by causing DNA chain termination after its incorporation into viral DNA. The inhibition constant (Ki) for adefovir diphosphate for HBV DNA polymerase was 0.1 μM. Adefovir diphosphate is a weak inhibitor of human DNA polymerases alpha and gamma with Ki values of 1.18 μM and 0.97μM, respectively. |
|---|
| Structure | CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C(N)N=CN=C12)OCOC(=O)C(C)(C)C InChI=1S/C20H32N5O8P/c1-19(2,3)17(26)30-11-32-34(28,33-12-31-18(27)20(4,5)6)13-29-8-7-25-10-24-14-15(21)22-9-23-16(14)25/h9-10H,7-8,11-13H2,1-6H3,(H2,21,22,23) |
|---|
| Synonyms | | Value | Source |
|---|
| Adefovir pivoxil | Kegg | | Hepsera | Kegg | | Adefovir | HMDB | | Adefovirdipivoxl | HMDB | | ADV | HMDB | | Bis-pom pmea | HMDB | | GS-840 | HMDB | | PMEA | HMDB | | Adefovir depivoxil | HMDB | | 9-(2-((-Bis((pivaloyloxy)methoxy)phosphinyl)methoxy)ethyl)adenine | HMDB | | Preveon | HMDB |
|
|---|
| Chemical Formula | C20H32N5O8P |
|---|
| Average Molecular Weight | 501.4705 |
|---|
| Monoisotopic Molecular Weight | 501.198849537 |
|---|
| IUPAC Name | [({[2-(6-amino-9H-purin-9-yl)ethoxy]methyl}({[(2,2-dimethylpropanoyl)oxy]methoxy})phosphoryl)oxy]methyl 2,2-dimethylpropanoate |
|---|
| Traditional Name | adefovir dipivoxil |
|---|
| CAS Registry Number | 142340-99-6 |
|---|
| SMILES | CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C(N)N=CN=C12)OCOC(=O)C(C)(C)C |
|---|
| InChI Identifier | InChI=1S/C20H32N5O8P/c1-19(2,3)17(26)30-11-32-34(28,33-12-31-18(27)20(4,5)6)13-29-8-7-25-10-24-14-15(21)22-9-23-16(14)25/h9-10H,7-8,11-13H2,1-6H3,(H2,21,22,23) |
|---|
| InChI Key | WOZSCQDILHKSGG-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as 6-aminopurines. These are purines that carry an amino group at position 6. Purine is a bicyclic aromatic compound made up of a pyrimidine ring fused to an imidazole ring. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organoheterocyclic compounds |
|---|
| Class | Imidazopyrimidines |
|---|
| Sub Class | Purines and purine derivatives |
|---|
| Direct Parent | 6-aminopurines |
|---|
| Alternative Parents | |
|---|
| Substituents | - 6-aminopurine
- Aminopyrimidine
- Dialkyl alkylphosphonate
- Phosphonic acid diester
- Dicarboxylic acid or derivatives
- Imidolactam
- Pyrimidine
- Phosphonic acid ester
- N-substituted imidazole
- Azole
- Heteroaromatic compound
- Imidazole
- Organophosphonic acid derivative
- Amino acid or derivatives
- Carboxylic acid ester
- Carboxylic acid derivative
- Azacycle
- Organophosphorus compound
- Primary amine
- Amine
- Hydrocarbon derivative
- Organic nitrogen compound
- Carbonyl group
- Organic oxide
- Organopnictogen compound
- Organic oxygen compound
- Organooxygen compound
- Organonitrogen compound
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | 0.63 g/L | Not Available | | LogP | 0.8 | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 4.71 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 12.0108 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 1.74 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 31.3 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 2767.2 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 161.1 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 169.7 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 134.0 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 76.9 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 471.7 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 431.4 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 78.8 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 929.4 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 486.4 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1298.9 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 290.6 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 363.1 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 127.9 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 111.1 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 8.3 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Adefovir Dipivoxil,1TMS,isomer #1 | CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C(N[Si](C)(C)C)N=CN=C21)OCOC(=O)C(C)(C)C | 3311.3 | Semi standard non polar | 33892256 | | Adefovir Dipivoxil,1TMS,isomer #1 | CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C(N[Si](C)(C)C)N=CN=C21)OCOC(=O)C(C)(C)C | 3239.4 | Standard non polar | 33892256 | | Adefovir Dipivoxil,1TMS,isomer #1 | CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C(N[Si](C)(C)C)N=CN=C21)OCOC(=O)C(C)(C)C | 5496.1 | Standard polar | 33892256 | | Adefovir Dipivoxil,2TMS,isomer #1 | CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C(N([Si](C)(C)C)[Si](C)(C)C)N=CN=C21)OCOC(=O)C(C)(C)C | 3275.4 | Semi standard non polar | 33892256 | | Adefovir Dipivoxil,2TMS,isomer #1 | CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C(N([Si](C)(C)C)[Si](C)(C)C)N=CN=C21)OCOC(=O)C(C)(C)C | 3301.7 | Standard non polar | 33892256 | | Adefovir Dipivoxil,2TMS,isomer #1 | CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C(N([Si](C)(C)C)[Si](C)(C)C)N=CN=C21)OCOC(=O)C(C)(C)C | 4718.8 | Standard polar | 33892256 | | Adefovir Dipivoxil,1TBDMS,isomer #1 | CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C(N[Si](C)(C)C(C)(C)C)N=CN=C21)OCOC(=O)C(C)(C)C | 3457.5 | Semi standard non polar | 33892256 | | Adefovir Dipivoxil,1TBDMS,isomer #1 | CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C(N[Si](C)(C)C(C)(C)C)N=CN=C21)OCOC(=O)C(C)(C)C | 3411.3 | Standard non polar | 33892256 | | Adefovir Dipivoxil,1TBDMS,isomer #1 | CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C(N[Si](C)(C)C(C)(C)C)N=CN=C21)OCOC(=O)C(C)(C)C | 5392.0 | Standard polar | 33892256 | | Adefovir Dipivoxil,2TBDMS,isomer #1 | CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)N=CN=C21)OCOC(=O)C(C)(C)C | 3610.2 | Semi standard non polar | 33892256 | | Adefovir Dipivoxil,2TBDMS,isomer #1 | CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)N=CN=C21)OCOC(=O)C(C)(C)C | 3625.3 | Standard non polar | 33892256 | | Adefovir Dipivoxil,2TBDMS,isomer #1 | CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)N=CN=C21)OCOC(=O)C(C)(C)C | 4661.5 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - Adefovir Dipivoxil GC-MS (Non-derivatized) - 70eV, Positive | splash10-0a4j-9715200000-be4793aa3b5324f2d049 | 2017-09-01 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Experimental LC-MS/MS | LC-MS/MS Spectrum - Adefovir Dipivoxil LC-ESI-qTof , Positive-QTOF | splash10-00b9-0291650000-bfacc10ec3119e8320f0 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Adefovir Dipivoxil , positive-QTOF | splash10-0kfx-1372940000-7cb1aa4d35fd2d90d7b4 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Adefovir Dipivoxil , positive-QTOF | splash10-00b9-0291650000-bfacc10ec3119e8320f0 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Adefovir Dipivoxil 10V, Positive-QTOF | splash10-0udi-1902120000-70d9218f4799e4b06e06 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Adefovir Dipivoxil 20V, Positive-QTOF | splash10-0r09-4902210000-8477053656f9d74eeb50 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Adefovir Dipivoxil 40V, Positive-QTOF | splash10-0a4r-6910000000-ff29d5990721f46c8df5 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Adefovir Dipivoxil 10V, Negative-QTOF | splash10-0f6t-0309020000-13dd87f577f6eae4df2c | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Adefovir Dipivoxil 20V, Negative-QTOF | splash10-0udi-0903000000-3c822353c37c29284a8f | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Adefovir Dipivoxil 40V, Negative-QTOF | splash10-001i-1922000000-607d6864a8d2801ab89f | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Adefovir Dipivoxil 10V, Positive-QTOF | splash10-0udr-5239180000-444adb50df8e9dcc8e3c | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Adefovir Dipivoxil 20V, Positive-QTOF | splash10-0fk9-0096000000-592e65840a6c7d4fec2b | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Adefovir Dipivoxil 40V, Positive-QTOF | splash10-000i-4972000000-f60e4d26bcfe1943e60c | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Adefovir Dipivoxil 10V, Negative-QTOF | splash10-0udi-0429260000-3e0596d28028aed80ce0 | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Adefovir Dipivoxil 20V, Negative-QTOF | splash10-0udi-1389000000-87f1f9b00d5ac0c19e44 | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Adefovir Dipivoxil 40V, Negative-QTOF | splash10-00di-0090000000-6582070f7152c5e52322 | 2021-10-11 | Wishart Lab | View Spectrum |
|
|---|